Baxter alerts providers to potential high-risk issues with devices
The Food and Drug Administration Dec. 31 released an alert highlighting a Baxter letter that recommended health care providers not use certain lots of Solution Sets with Duo-Vent Spikes due to a potentially high-risk issue. Baxter reported that some affected products were incorrectly assembled with inverted slide clamps.
The affected products include:
• Solution Set with Duo-Vent Spike, lot DR24C22079, expiration March 24, 2026, and lot DR24H23086, expiration Aug. 26, 2026.
• Clearlink System Solution Set with Duo-Vent Spike, lot DR24C15109, expiration March 16, 2026.
• Continu-Flo Solution Set with Duo-Vent Spike, 2 Luer Activated Valves, Male Luer Lock Adapter with Retractable Collar, lot DR24B21017, expiration Feb. 28, 2026.
Related News Articles
Headline
The Food and Drug Administration May 23 announced that Medline Industries, a firm marketing and distributing Chinese-manufactured plastic syringes within the U…
Headline
The Food and Drug Administration yesterday announced an import alert for plastic syringes manufactured by two China-based manufacturers, in addition to…
Headline
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing…
Headline
U.S. health care organizations should immediately transition away from using certain unauthorized plastic syringes made in China by Jiangsu Caina Medical Co.…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
In updated guidance for makers of medical devices labeled as sterile, the Food and Drug Administration Jan. 8 listed vaporized hydrogen peroxide as an…